CYTOKINES AND SEPSIS - WHAT ARE THE THERAPEUTIC IMPLICATIONS

被引:14
作者
CHRISTMAN, JW
WHEELER, AP
BERNARD, GR
机构
[1] Departments of Veterans Affairs and Medicine, Center for Lung Research, Vanderbilt University, Nashville, TN
关键词
D O I
10.1016/0883-9441(91)90008-H
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Although data with regard to cytokine action are rapidly emerging at the molecular and cell level, animal and human data are lagging. Deciphering the mechanisms of action and interrelationships of these proteins will take some time given their complexity. Such work will take animal models to task with respect to their relevance to human disease. Human investigations may be even more difficult due to the number and complexity of the cytokines. On the other band, greatly speeding the process is the ready availability of amino acid sequencing, cloning techniques for production of chemically pure cytokines, and polyclonal and monoclonal antibodies to the cytokines and their receptors. Still, a conservative estimate would predict that years will be required to take research from the bench to the bedside. In the final analysis, the potential benefits of cytokine research are immense, not only in sepsis but in the variety of other diseases. © 1991.
引用
收藏
页码:172 / 182
页数:11
相关论文
共 104 条
  • [1] Kreger, Craven, McCabe, Gram-negative bacteremia. IV. Reevaluation of clinical features and treatment of 612 patients, Am J Med, 68, pp. 344-355, (1980)
  • [2] Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis, New England Journal of Medicine, 317, pp. 659-665, (1987)
  • [3] Bone, Fisher, Clemmer, Et al., A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock, N Engl J Med, 317, pp. 653-658, (1987)
  • [4] Danner, Elin, Hosseini, Et al., Endotoxemia in human septic shock, Chest, 99, pp. 169-175, (1991)
  • [5] Ziegler, Tumor necrosis factor in humans, N Engl J Med, 318, pp. 1533-1535, (1988)
  • [6] Beutler, Cerami, Cachectin: More than a tumor necrosis factor, N Engl J Med, 316, pp. 379-385, (1986)
  • [7] Sherry, Cerami, Cachectin/tumor necrosis factor exerts endocrine, paracrine, and autocrine control of inflammatory responses, J Cell Biol, 107, pp. 1269-1277, (1988)
  • [8] Wang, Creasey, Ladner, Et al., Molecular cloning of the complementary DNA for human tumor necrosis factor, Science, 228, pp. 149-154, (1985)
  • [9] Luettig, Decker, Lohmann-Matthes, Evidence for the existence of two forms of a membrane tumor necrosis factor: An integral protein and a molecule attached to its receptor, J Immunol, 143, pp. 4034-4038, (1989)
  • [10] Schall, Lewis, Koller, Et al., Molecular cloning and expression of a receptor for human tumor necrosis factor, Cell, 61, pp. 361-370, (1990)